Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Recommendation of “Hold” by Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has been given a consensus recommendation of “Hold” by the four analysts that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $4.00.

Several analysts have recently commented on BIOX shares. Wall Street Zen downgraded Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, April 4th. Weiss Ratings lowered Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a report on Monday, July 13th.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of large investors have recently modified their holdings of the company. Invesco Ltd. bought a new stake in Bioceres Crop Solutions during the 4th quarter valued at $45,000. Ardsley Advisory Partners LP lifted its stake in shares of Bioceres Crop Solutions by 691.7% in the fourth quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock valued at $622,000 after buying an additional 415,000 shares in the last quarter. GAM Holding AG bought a new position in shares of Bioceres Crop Solutions in the fourth quarter valued at $655,000. State of Wisconsin Investment Board acquired a new position in shares of Bioceres Crop Solutions during the fourth quarter valued at about $247,000. Finally, Marshall Wace LLP increased its position in shares of Bioceres Crop Solutions by 180.0% during the fourth quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock worth $780,000 after acquiring an additional 382,744 shares in the last quarter. 17.68% of the stock is currently owned by institutional investors.

Bioceres Crop Solutions Trading Up 0.7%

NASDAQ BIOX traded up $0.00 during mid-day trading on Thursday, reaching $0.33. 2,897 shares of the stock were exchanged, compared to its average volume of 557,329. Bioceres Crop Solutions has a one year low of $0.30 and a one year high of $3.75. The stock has a 50 day simple moving average of $0.38 and a 200-day simple moving average of $0.55. The stock has a market cap of $20.55 million, a P/E ratio of -0.08 and a beta of 0.42. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.88 and a quick ratio of 0.70.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Monday, May 11th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.11). The business had revenue of $39.40 million during the quarter, compared to the consensus estimate of $54.50 million. Bioceres Crop Solutions had a negative return on equity of 33.97% and a negative net margin of 92.85%.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.